Literature DB >> 16138205

Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru.

Luis Marcos1, Vicente Maco, Angélica Terashima, Frine Samalvides, José R Espinoza, Eduardo Gotuzzo.   

Abstract

High prevalence rates of human fascioliasis have been described in several regions of Peru. We surveyed 20 families in an endemic area of Peru in order to determine the proportion of infection with F. hepatica in relatives of diagnosed subjects and in order to identify associated risk factors. The study included feces and blood samples of 93 subjects. Ages ranged from one to 53 (mean = 18.6; SD = 14.2). The overall prevalence of fascioliasis by fecal examinations was 33.3% (n = 83) and by serology, 51.9% (n = 86). The prevalence in age group I (< or = 19 years old) by coprological and serological tests was 61.4% and 75.9%, respectively; in group II (> 19 years old) 15.4% and 37.5%. The main associated risk factor with fascioliasis was eating salads (OR = 3.29, CI = 1.2 - 9.0, p = 0.02). In conclusion, human fascioliasis is highly prevalent in the relatives of index cases and the most significant risk factor of acquiring fascioliasis in the family is eating salads in endemic areas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138205     DOI: 10.1590/s0036-46652005000400008

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis.

Authors:  Adelaida Morales; Ana M Espino
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

2.  First Report of Human Fascioliasis in an Endemic Region of Bovine Fascioliasis in Caldas-Colombia.

Authors:  Jorge Enrique Perez-C; Etna Julieth Giraldo-Pinzon; Sandra Aguilar-Marín
Journal:  Vector Borne Zoonotic Dis       Date:  2016-04-05       Impact factor: 2.133

3.  The Endemicity of Human Fascioliasis in Guilan Province, Northern Iran: the Baseline for Implementation of Control Strategies.

Authors:  Keyhan Ashrafi; Farshid Saadat; Sandra O'Neill; Behnaz Rahmati; Hadid Amin Tahmasbi; John Pius Dalton; Abolhassan Nadim; Mohsen Asadinezhad; Sayed Mahmood Rezvani
Journal:  Iran J Public Health       Date:  2015-04       Impact factor: 1.429

Review 4.  Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.

Authors:  Maria Alejandra Caravedo; Miguel Mauricio Cabada
Journal:  Res Rep Trop Med       Date:  2020-11-26

5.  Seroepidemiology of human fascioliasis and its relationship with anti-Fasciola IgG and liver enzymes as biomarkers of pathogenicity.

Authors:  Kiran Afshan; Saman Kabeer; Sabika Firasat; Sarwat Jahan; Mazhar Qayyum
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

6.  Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola Gigantica that cause the zoonosis Fasciolosis.

Authors:  Richard Lalor; Krystyna Cwiklinski; Nichola Eliza Davies Calvani; Amber Dorey; Siobhán Hamon; Jesús López Corrales; John Pius Dalton; Carolina De Marco Verissimo
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  The role of medical students in the fight to control neglected tropical diseases: a view from Peru.

Authors:  Javier Villafuerte-Galvez; Walter H Curioso; J Jaime Miranda
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.